These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 39312884)

  • 1. " LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the LumiThera Valeda Light Delivery System ".
    Boyer D; Munk MR; Tedford SE; Croissant CL; Rückert R; Tedford CE
    Retina; 2024 Nov; 44(12):e83-7. PubMed ID: 39312884
    [No Abstract]   [Full Text] [Related]  

  • 2. LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System.
    Boyer D; Hu A; Warrow D; Xavier S; Gonzalez V; Lad E; Rosen RB; Do D; Schneiderman T; Ho A; Munk MR; Jaffe G; Tedford SE; Croissant CL; Walker M; Rückert R; Tedford CE
    Retina; 2024 Mar; 44(3):487-497. PubMed ID: 37972955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter to the Editor: LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the LumiTheraTM Valeda Light Delivery System.
    Feltgen N; Ach T; Bartz-Schmidt U; Bechrakis N; Eter N; Hattenbach L; Heimann H; Hoerauf H; Lommatzsch A; Priglinger S; Stahl A; Walter P; Wolf A; Ziemssen F; Grisanti S
    Retina; 2024 Sep; ():. PubMed ID: 39316834
    [No Abstract]   [Full Text] [Related]  

  • 4. LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration.
    Burton B; Parodi MB; Jürgens I; Zanlonghi X; Hornan D; Roider J; Lorenz K; Munk MR; Croissant CL; Tedford SE; Walker M; Ruckert R; Tedford CE
    Ophthalmol Ther; 2023 Apr; 12(2):953-968. PubMed ID: 36588113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Invasive Treatment of Early Diabetic Macular Edema by Multiwavelength Photobiomodulation with the Valeda Light Delivery System.
    Kaymak H; Munk MR; Tedford SE; Croissant CL; Tedford CE; Ruckert R; Schwahn H
    Clin Ophthalmol; 2023; 17():3549-3559. PubMed ID: 38026594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION.
    Markowitz SN; Devenyi RG; Munk MR; Croissant CL; Tedford SE; Rückert R; Walker MG; Patino BE; Chen L; Nido M; Tedford CE
    Retina; 2020 Aug; 40(8):1471-1482. PubMed ID: 31404033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Response to: Letter to the Editor Regarding "LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration".
    Burton B; Munk MR; Tedford SE; Croissant CL; Rückert R; Tedford CE
    Ophthalmol Ther; 2024 Apr; 13(4):1055-1060. PubMed ID: 38319553
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiwavelength photobiomodulation in atrophic age-related macular degeneration.
    Beretta F; Zucchiatti I; Sacconi R; Bandello F; Querques G
    Eur J Ophthalmol; 2024 Nov; ():11206721241298316. PubMed ID: 39544046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter to the Editor Regarding "LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration".
    Grisanti S; Bartz-Schmidt KU; Heimann H; Lommatzsch A; Walter P; Ach T
    Ophthalmol Ther; 2024 Apr; 13(4):1051-1053. PubMed ID: 38319554
    [No Abstract]   [Full Text] [Related]  

  • 10. Emerging Therapies in Nonexudative Age-Related Macular Degeneration in 2020.
    Samanta A; Aziz AA; Jhingan M; Singh SR; Khanani AM; Chhablani J
    Asia Pac J Ophthalmol (Phila); 2021 Jan; 10(4):408-416. PubMed ID: 33512911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHOTOBIOMODULATION THERAPY FOR LARGE SOFT DRUSEN AND DRUSENOID PIGMENT EPITHELIAL DETACHMENT IN AGE-RELATED MACULAR DEGENERATION: A Single-Center Prospective Pilot Study.
    Benlahbib M; Cohen SY; Torrell N; Colantuono D; Crincoli E; Amoroso F; Semoun O; Jung C; Souied EH
    Retina; 2023 Aug; 43(8):1246-1254. PubMed ID: 37027819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photobiomodulation therapy in age-related macular degeneration.
    Muste JC; Kalur A; Iyer A; Valentim CCS; Singh RP
    Curr Opin Ophthalmol; 2021 May; 32(3):225-232. PubMed ID: 33606405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age-related macular degeneration.
    Merry GF; Munk MR; Dotson RS; Walker MG; Devenyi RG
    Acta Ophthalmol; 2017 Jun; 95(4):e270-e277. PubMed ID: 27989012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical Coherence Tomography Angiography for Detecting Nonexudative Macular Neovascularization in Age-Related Macular Degeneration.
    Greenberg JR; Kim BY; Brady CJ; Millay RH; Raut R
    J Vitreoretin Dis; 2023; 7(1):16-19. PubMed ID: 37008398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Color Doppler imaging discloses reduced ocular blood flow velocities in nonexudative age-related macular degeneration.
    Ciulla TA; Harris A; Chung HS; Danis RP; Kagemann L; McNulty L; Pratt LM; Martin BJ
    Am J Ophthalmol; 1999 Jul; 128(1):75-80. PubMed ID: 10482097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity.
    Wang Y; Sun J; Wu J; Jia H; Feng J; Chen J; Yan Q; Huang P; Wang F; Bo Q; Sun X
    Eye (Lond); 2023 Jul; 37(10):2048-2054. PubMed ID: 36434285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration.
    Borrelli E; Coco G; Pellegrini M; Mura M; Ciarmatori N; Scorcia V; Carnevali A; Lucisano A; Borselli M; Rossi C; Reibaldi M; Ricardi F; Vagge A; Nicolò M; Forte P; Cartabellotta A; Hasanreisoğlu M; Kesim C; Demirel S; Yanık Ö; Bernabei F; Rothschild PR; Farrant S; Giannaccare G
    Ophthalmol Ther; 2024 Nov; 13(11):2855-2868. PubMed ID: 39271642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in Central Serous Chorioretinopathy Following Multiwavelength Photobiomodulation Treatment - Case Report.
    Sachdev A
    Ophthalmol Ther; 2024 Jul; 13(7):2055-2060. PubMed ID: 38758517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic Predictors and Temporal Characteristics of Conversion from Nonexudative to Exudative Age-Related Macular Degeneration in the Fellow Eye.
    Teo KYC; Yanagi Y; Wong TY; Charkaravarty U; Gemmy Cheung CM
    Ophthalmol Retina; 2021 Feb; 5(2):126-140. PubMed ID: 32679204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of nonexudative and exudative age-related macular degeneration among Asian American ethnic groups.
    Stein JD; Vanderbeek BL; Talwar N; Nan B; Musch DC; Zacks DN
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6842-8. PubMed ID: 21778274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.